We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bioject Medical Technologies, a developer of needle-free drug delivery systems,
has entered into a supply agreement with Chronimed, a specialty pharmacy that
distributes pharmaceuticals and provides specialized patient management services
for people with HIV/AIDS.
Cardiovascular Systems has received marketing clearance from the FDA for the
company's Orbital Atherectomy System used to remove tissue causing stenosis
in synthetic AV shunts.
BioElectronics, a developer and marketer of disposable, drug-free medical devices,
has announced that its ActiPatch Therapy product is in clinical trials with
a major pharmaceutical foot care company.
Avitar has entered into a Standby Equity Distribution
Agreement with Cornell Capital Partners, LP. Under the deal, signed as of Feb.
1, 2005, Cornell Capital is committed to provide up to $10 million of equity
financing which can be drawn by the company in $250,000 tranches at any time
over a 24-month period, subject to certain conditions and obligations.
Zimmer Holdings has acquired U.S. distribution rights for the Palacos line of
bone cement products manufactured by Heraeus Kulzer of Germany, a developer
and producer of orthopedic bone cement products and other healthcare technologies.
Align Technology, the inventor of Invisalign, a proprietary method of straightening
teeth without wires and brackets, has filed a multiclaim lawsuit in San Francisco
County Superior Court against defendants OrthoClear, OrthoClear Holdings, Muhammad
Ziaullah Chishti, Bao Tran, Peter Riepenhausen, Joe Breeland, Jeff Tunnell,
Christopher Kawaja and Charles Wen. Among other things, the lawsuit alleges
tortious and illegal actions arising out of defendants' plan to unlawfully utilize
Align's intellectual property, confidential information and employees.
BioGenex Laboratories has received the premarket approval from FDA for its InSite
Her-2/neu Kit. This in vitro diagnostic kit is used to identify breast cancer
patients eligible for treatment with the cancer drug Herceptin (Trastuzumab).
Cambridge Consultants has designed an intelligent radio transceiver architecture
that introduces a new level of power economy and performance for in-body medical
diagnostic and therapeutic applications.
Eastman Kodak has formed an alliance with TUV Rheinland of North America to
provide regulatory compliance and testing services to Kodak and other companies
worldwide.
Laboratory Corporation of America (LabCorp) has completed its previously announced
acquisition of U.S. Pathology Labs, a provider of anatomic pathology and oncology
testing services with a focus on the outpatient market.